Hybrid mesh for sports hernia repair
Mini-invasive Surgery · 2017
DOI: 10.20517/2574-1225.2016.05 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mini-invasive Surgery, 2017. Verfasst von David S. Edelman. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Aim
Mesh is commonly utilized in the laparoscopic repair of sports hernias. A hybrid mesh was recently released containing a single light weight layer of macroporous, polypropylene mesh between layers of biologic mesh. Having an extensive experience with laparoscopic and sports hernia repairs, a small sample of hybrid mesh was trialed.
Methods
From April 2015 to August 2016, 16 male patients with sports hernias were consented for hybrid mesh repair. A prospective data base was developed and patients were followed at 1 week, 4 weeks and 4 months after surgery.
Results
Ages ranged from 18 years to 43 years (average 22.9 years). Operative times ranged from 25 min to 75 min (average 42.5 min). All were athletes playing basketball, soccer, baseball, football and track. There were no operative problems. Two patients developed post-operative seromas requiring radiologic drainage. All patients completed a postoperative therapy program and all have returned to their sport without problems.
Conclusion
There is not one type of mesh repair that has been proven to be the most effective treatment for sports hernias. Continued follow up as well as a more structured study will be necessary to prove if hybrid mesh has long term effectiveness for the laparoscopic treatment of sports hernias. The initial study has promising findings.
Zitieren
APA
Edelman, D. S. (2017). Hybrid mesh for sports hernia repair. Mini-invasive Surgery. https://doi.org/10.20517/2574-1225.2016.05
Vancouver
Edelman DS. Hybrid mesh for sports hernia repair. Mini-invasive Surgery. 2017. doi:10.20517/2574-1225.2016.05
BibTeX
@article{Edelman2017,
author = {Edelman, David S.},
title = {Hybrid mesh for sports hernia repair},
journal = {Mini-invasive Surgery},
year = {2017},
doi = {10.20517/2574-1225.2016.05}
}
EUVIMED